Myoclonus in patients treated with etanercept

Myoclonus in patients treated with etanercept

Saved in:

Bibliographic Details
Main Authors:	V. Domínguez Leñero, I. Sánchez-Martínez, M. E. Giménez-Cortés, F. Valiente-Borrego
Format:	Article
Language:	English
Published:	Elsevier 2014-01-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/1109.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Acute Q Fever in an Ankylosing Spondyloarthritis Patient Treated with Etanercept
by: A. Guiga, et al.
Published: (2021-01-01)

Myoclonus
by: R. Rimšienė, et al.
Published: (2020-12-01)

Inefficacy or Paradoxical Effect? Uveitis in Ankylosing Spondylitis Treated with Etanercept
by: Bernd Raffeiner, et al.
Published: (2014-01-01)

Lung Sarcoidosis in Etanercept Treated Rheumatoid Arthritis Patient: A Case Report and Review of the Literature
by: Supat Thongpooswan, et al.
Published: (2014-01-01)

Myoclonus associated with Ciprofloxacin therapy
by: Esperanza Bueno Juana, et al.
Published: (2016-12-01)

Unexpected multiple sclerosis‐like symptoms in a rheumatoid arthritis patient treated with Etanercept: A case report
by: Ali Hosseinpour, et al.
Published: (2024-11-01)

Etanercept-Induced Pityriasis Lichenoides Chronica in a Patient with Rheumatoid Arthritis
by: Andrés F. Echeverri, et al.
Published: (2015-01-01)

Relapsing Polychondritis in a Patient with Ankylosing Spondylitis Using Etanercept
by: Valderilio Feijó Azevedo, et al.
Published: (2014-01-01)

Clinical experience with two etanercept biosimilars in Indian patients with spondyloarthritis
by: Ashok Kumar, et al.
Published: (2017-01-01)

Giant Cell Myocarditis in a Patient With Crohn's Disease, Treated with Etanercept – A Tumour Necrosis Factor-Alpha Antagonist
by: C Nash, et al.
Published: (2001-01-01)

Treatment of Palatal Myoclonus with Botulinum Toxin Injection
by: Mursalin M. Anis, et al.
Published: (2013-01-01)

Auricular Myoclonus: A Case Report and Literature Review
by: Christopher E. Jabbour, et al.
Published: (2021-11-01)

Drug-Induced Myoclonus: A Systematic Review
by: Jamir Pitton Rissardo, et al.
Published: (2025-01-01)

21642. SÍNDROME DE PERM (PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY AND MYOCLONUS) SEROPOSITIVO, A PROPÓSITO DE UN CASO
by: M. Benavent Giménez, et al.
Published: (2024-11-01)

Presumed gabapentin-induced myoclonus in two cats
by: Caroline Buckley, et al.
Published: (2024-11-01)

Psychiatric and Behavioral Complications of GPi DBS in an Adolescent with Myoclonus Dystonia
by: Graciela Kriegel, et al.
Published: (2019-01-01)

Valproic Acid-Induced Myoclonus in a Demented Patient: A Case Report
by: Tina M. Gardner, et al.
Published: (2009-01-01)

Amisulpride-induced myoclonus: A unique tardive syndrome
by: Shreyashi Jha, et al.
Published: (2024-11-01)

Etanercept on steroid-refractary acute graft-versus-host disease
by: Silvia González Munguía, et al.
Published: (2015-02-01)

Opsoclonus-myoclonus syndrome in the course of teratoma: a case report
by: Mateusz Szczupak, et al.
Published: (2025-01-01)

Characteristics and clinical course of myoclonus in Cavalier King Charles Spaniels
by: Matthew James, et al.
Published: (2025-01-01)

Clinical and nerve electrophysiological features of patients with propriospinal myoclonus: A report of 5 cases
by: WEN Xinyu, WEN Wenhao, YANG Lei
Published: (2024-12-01)

Intertoe Squamous Cell Carcinoma Developed in a Patient with Rheumatoid Arthritis under Etanercept Therapy
by: Efstathios Rallis, et al.
Published: (2015-01-01)

Etanercept: A viable treatment option for young children with generalized pustular psoriasis
by: Yunliu Chen, et al.
Published: (2024-12-01)

Acute Generalized Exanthematous Pustulosis Induced by Etanercept: Another Dermatologic Adverse Effect
by: Mukaddes Kavala, et al.
Published: (2013-01-01)

Retinal vascular pathology in a mouse model of Lafora progressive myoclonus epilepsy
by: Ruchira Pranay Patil, et al.
Published: (2024-07-01)

Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
by: Mariana P. Miranda-Hernández, et al.
Published: (2018-01-01)

Efficacy, safety, and immunogenicity of biosimilars compared with the biologic etanercept in patients with rheumatoid arthritis: a systematic review and meta-analysis
by: Aurélio Matos Andrade, et al.
Published: (2024-11-01)

“Dancing Eye Syndrome” Secondary to Opsoclonus-Myoclonus Syndrome in Small-Cell Lung Cancer
by: S. Laroumagne, et al.
Published: (2014-01-01)

Opsoclonus myoclonus ataxia syndrome, ovarian teratoma and anti-NMDAR antibody: an ‘unresolved’ mystery
by: Vivek Mathew, et al.
Published: (2023-06-01)

Familial Creutzfeldt-Jakob Disease with early onset myoclonus: A case for fulminant progression
by: Indira Naskar, et al.
Published: (2023-07-01)

Inhibition of tumour necrosis factor alpha by Etanercept attenuates Shiga toxin-induced brain pathology
by: Robin Christ, et al.
Published: (2025-02-01)

Successful treatment of etanercept- and adalimumab-resistant pyoderma gangrenosum with spesolimab, moderate-dose corticosteroids, and minocycline
by: Hanlin Zhang, et al.
Published: (2025-12-01)

Management of pediatric steroid-refractory graft versus host disease: Challenges and outcome with ruxolitinib and etanercept
by: Sanjana Sarangarajan, et al.
Published: (2024-01-01)

Effectiveness of Traditional Chinese Medicine-Based Acupuncture Therapy in Managing Myoclonus in Generalized Dystonia: A Case Report
by: J. Anbudasan, et al.
Published: (2024-11-01)

Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial
by: Selma Atalay, et al.
Published: (2022-07-01)

Pretreatment with Esketamine Reduces Etomidate-Induced Myoclonus During the Induction of Anesthesia: A Randomized Controlled Trial
by: Wang J, et al.
Published: (2024-12-01)

The utilization of the multimodal immunotherapy for the opsoclonus–myoclonus syndrome can reduce relapses and permanent neurological sequelae
by: Fang He, et al.
Published: (2025-02-01)

Clinical efficacy of low‐dose Perampanel correlates with neurophysiological changes in familial adult myoclonus epilepsy 2
by: Antonietta Coppola, et al.
Published: (2025-02-01)

Effect of Pretreatment with a Small Dose of Esketamine on Myoclonus Induced by Etomidate: A Randomized Controlled Trial
by: Gao L, et al.
Published: (2024-12-01)